Rhinosinusitis (RS) is a heterogeneous group of diseases. It is a significant and increasing
health problem that affects about 15% of the population in Western countries. It has a …

Chronic rhinosinusitis (CRS), a disease presenting with chronic symptoms such as nasal
obstruction, rhinorrhea, hyposmia and facial pain, is highly prevalent and has a …

Therapeutic Targets in Rhinosinusitis: Infection or Inflammation? - PMC Back to Top Skip to
main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content …

Chronic rhinosinusitis, historically, has been considered to be caused by upper airway
anatomical abnormalities. However, today that concept has changed, for it is now …

Chronic rhinosinusitis (CRS) is an important ENT pathology which affects about 5–12% of
the general population. The treatment of CRS can be pharmacological (nasal sprays …

Chronic rhinosinusitis (CRS) is a heterogeneous group of inflammatory diseases of the
nasal and paranasal cavities either accompanied by polyp formation (CRSwNP) or without …

Chronic rhinosinusitis (CRS) is a common disease that affects> 10% of the adult population
in Europe and the United States. It has been delineated phenotypically into CRS without …

Despite the high prevalence of chronic rhinosinusitis (CRS) worldwide, the exact
pathogenesis of the disease remains unknown. Even with therapeutic intervention, treatment …

Chronic rhinosinusitis is a heterogeneous group of chronic sinus diseases that may consist
of clearly different disease entities. Further investigation of the pathomechanisms of chronic …

Adult chronic rhinosinusitis (CRS) is a chronic inflammation of the mucosa of the nose and
paranasal sinuses. According to the latest EPOS guidelines CRS should be regarded as …